Role of Mesh in Laparoscopic Sacropexy Surgical Techniques for the Treatment of Female Genital Prolapse
- Conditions
- Female Genital Prolapse
- Registration Number
- NCT06720831
- Brief Summary
This study aims to determine the rate of recurrence of central pelvic organ prolapse in patients who have undergone surgery (sacropexy with and without mesh) for the same pathology.
- Detailed Description
There is a lack of data in the literature comparing sacroplexing with the use of mesh with sacroplexing performed without the use of mesh in terms of recurrence, improvement in symptoms, and restoration of normal pelvic organ prolapse relationships. The objective of this study is to determine the rate of recurrence of central pelvic organ prolapse in patients with a clinical diagnosis of genital prolapse stage ≥ 2 according to the POP-Q classification who underwent laparoscopic sacroplasty with mesh (group 1) and without mesh (group 2). The study may provide information on the impact of mesh in laparoscopic surgery for the correction of central pelvic organ prolapse.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 160
- Age ≥ 18 years
- Clinical diagnosis of genital prolapse stage ≥ 2 according to POP-Q classification
- Surgical treatment of laparoscopic sacropexy by mesh (group 1) and without (group 2) in female patients
- Acquisition of informed consent
- At least one follow-up evaluation at 24 months
- Age > 80 years
- Previous genital prolapse surgery
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence rate of central pelvic organ prolapse 24 months after surgery The rate of recurrence of central pelvic organ prolapse in patients with a clinical diagnosis of genital prolapse stage ≥ 2 according to the POP-Q classification, undergoing sacroplasty with and without mesh
- Secondary Outcome Measures
Name Time Method Recurrence rate of central pelvic organ prolapse in laparoscopic sacral hysteropexy, sacralcervicopexy and sacralcolpopexy 24 months after surgery The rate of pelvic organ prolapse recurrence in patients treated with mesh (group 1) and without (group 2) in the laparoscopic sacral hysteropexy, sacralcervicopexy and sacralcolpopexy
Rate of intraoperative and postoperative complications During surgery and within 30 days Evaluation of intraoperative and postoperative complications according to the Clavien-Dindo classification
Modification of symptoms after surgery Before surgery and 24 months after surgery Change in pre- and post-operative symptomatology assessed through the completion of a questionnaire
Changes in the disease framework Before surgery and 24 months after surgery Change in the disease framework of pelvic organ prolapse according to the POP-Q classification assessed before and after surgery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
🇮🇹Bologna, Italy
Azienda Ospedaliera Universitaria Integrata di Verona
🇮🇹Verona, Italy